Study of cetuximab in squamous cell carcinoma of the skin expressing EGFR

Journal of Drugs in Dermatology, May, 2007

Sponsors and Collaborators: Centre Hospitalier of Chartres and Hospital of Chartres-France. The purpose of this study is to determine whether cetuximab is effective in the treatment of locally advanced or metastatic squamous cell carcinoma of the skin expressing the epidermal growth factor receptor (EGFR).

Condition                 Intervention     Phase

Skin Diseases             Drug: cetuximab  Phase II
Carcinoma, Squamous Cell

Study ID Numbers: 2005-001098-82

ClinicalTrials.gov Identifier: NCT00240682